Health Canada drug identification number

DIN 02483076 — UNITUXIN 3.5 MG

UNITUXIN is a solution of Dinutuximab marketed by UNITED THERAPEUTICS CORPORATION. The full Dinutuximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02483076
Brand name
UNITUXIN
Active ingredient
Dinutuximab
Strength
3.5 MG
Dosage form
SOLUTION
Route
INTRAVENOUS
Manufacturer
UNITED THERAPEUTICS CORPORATION
Health Canada status
MARKETED
Drug class
Anti-GD2 monoclonal antibody (antineoplastic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.